Recent Podcasts

News Briefs


Take Our Survey
Click Here to take our survey.



Pharma Marketing Network Forums
The Leading Online Community of Pharmaceutical Marketing Experts
| Newsletter | Conferences | Podcasts | Glossary | Surveys | Blog | Vendor Directory | Advertising Information | Contact Us

Pharma Marketing Blog
"Must Read Blog for Insiders."
-- Wall Street Journal
Pharma Marketing News
January 2010 Issue of Pharma Marketing News Available!

Go Back   Pharma Marketing Network Forums > News & Views > Pharma Marketing Blog

Pharma Marketing Blog This forum is where you find notices of posts made to Pharma Marketing Blog and other blogs focused on the pharmaceutical industry.

Reply
 
Thread Tools Rate Thread Display Modes
  #1  
Old 19th September 2009, 11:53 AM
JohnMack's Avatar
JohnMack JohnMack is offline
Platinum Member
 
Join Date: Jan 2007
Location: Newtown, PA
Posts: 5,912
Default FDA Announces Public Hearing on Promotion of Drugs on Internet & via Social Media. Th

On April 1, 2009, my "April Fool's" joke press release announcing that the FDA issued draft guidance for use of social media for Rx drug marketing created quite a stir among pharmaceutical industry pundits and executives (see "FDA Issues First-ever Draft Guidance on Pharma’s Use of Social Media!").

Later that month, I drafted a petition calling upon the FDA to convene a public hearing on the issue. The petition stated:
"...it is necessary for the FDA to convene a PUBLIC HEARING where ALL stakeholders can participate in a discussion of the issues and provide the FDA with a good understanding of the Internet as it exists today and tomorrow. That understanding and knowledge can then be the basis for issuing guidance that will allow the pharmaceutical industry to contribute to the conversation online" (see "FDA, Tear Down This Wall! A Draft Petition Calling for a Public Hearing").
Well, the FDA has now actually submitted a notice to the Federal Register (to be published Monday, September 21, 2009) calling for a public hearing on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools:
Docket No. FDA-2009-N-0441, CDER 200994. Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools; Notice of Public Hearing (Notice of public hearing; request for comments). [OFR PRE-PUB: PDF of notice or see attachment to this post] Public Hearing on November 12, 2009 And November 13, 2009 Comments due February 28, 2010
The pharmaceutical industry and readers of this blog have long supported such a hearing. See this Pharma Marketing News article:
"Developing Guidelines for Pharma's Use of the Internet & Social Media" (FREE!) to see the results of the survey "Should FDA Convene a Public Hearing on Use of Social Media by Pharma?"

https://blogger.googleusercontent.co...g.blogspot.com


Access original post with comments here...
Attached Images
File Type: pdf FDA-InetPubHearing-announce-Nov09.pdf (33.5 KB, 1 views)
__________________
John Mack, Editor & Publisher
***********************
Follow me on TWITTER:
http://twitter.com/pharmaguy
***********************
Pharma Marketing News
www.pharmamarketingnews.com
johnmack@virsci.com
215-504-4164 * 215-504-5739 (Fax)

Last edited by Pharma Newshound : 21st September 2009 at 11:36 AM.
Reply With Quote
  #2  
Old 4th October 2009, 01:57 AM
radiant's Avatar
radiant radiant is offline
Member
 
Join Date: Aug 2009
Location: US
Posts: 15
Default

wow thats great to hear. Once its licensed, pharmaceuticals do not have to sneak in and to a great extent spams would be reduced on the internet.
Reply With Quote
Reply


Thread Tools
Display Modes Rate This Thread
Rate This Thread:

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump


All times are GMT -5. The time now is 08:55 AM.


Powered by vBulletin® Version 3.6.4
Copyright ©2000 - 2010, Jelsoft Enterprises Ltd.
(c) 2009, VirSci Corporation. All rights reserved.